The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
- PMID: 9794851
- PMCID: PMC28700
- DOI: 10.1136/bmj.317.7167.1185
The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
Abstract
Objective: To summarise comparisons of randomised clinical trials and non-randomised clinical trials, trials with adequately concealed random allocation versus inadequately concealed random allocation, and high quality trials versus low quality trials where the effect of randomisation could not be separated from the effects of other methodological manoeuvres.
Design: Systematic review.
Selection criteria: Cohorts or meta-analyses of clinical trials that included an empirical assessment of the relation between randomisation and estimates of effect.
Data sources: Cochrane Review Methodology Database, Medline, SciSearch, bibliographies, hand searching of journals, personal communication with methodologists, and the reference lists of relevant articles.
Main outcome measures: Relation between randomisation and estimates of effect.
Results: Eleven studies that compared randomised controlled trials with non-randomised controlled trials (eight for evaluations of the same intervention and three across different interventions), two studies that compared trials with adequately concealed random allocation and inadequately concealed random allocation, and five studies that assessed the relation between quality scores and estimates of treatment effects, were identified. Failure to use random allocation and concealment of allocation were associated with relative increases in estimates of effects of 150% or more, relative decreases of up to 90%, inversion of the estimated effect and, in some cases, no difference. On average, failure to use randomisation or adequate concealment of allocation resulted in larger estimates of effect due to a poorer prognosis in non-randomly selected control groups compared with randomly selected control groups.
Conclusions: Failure to use adequately concealed random allocation can distort the apparent effects of care in either direction, causing the effects to seem either larger or smaller than they really are. The size of these distortions can be as large as or larger than the size of the effects that are to be detected.
Similar articles
-
Impact of Selection Bias on Treatment Effect Size Estimates in Randomized Trials of Oral Health Interventions: A Meta-epidemiological Study.J Dent Res. 2018 Jan;97(1):5-13. doi: 10.1177/0022034517725049. Epub 2017 Aug 16. J Dent Res. 2018. PMID: 28813182
-
Evaluating non-randomised intervention studies.Health Technol Assess. 2003;7(27):iii-x, 1-173. doi: 10.3310/hta7270. Health Technol Assess. 2003. PMID: 14499048 Review.
-
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.JAMA. 1995 Feb 1;273(5):408-12. doi: 10.1001/jama.273.5.408. JAMA. 1995. PMID: 7823387
-
What is the influence of randomisation sequence generation and allocation concealment on treatment effects of physical therapy trials? A meta-epidemiological study.BMJ Open. 2015 Sep 3;5(9):e008562. doi: 10.1136/bmjopen-2015-008562. BMJ Open. 2015. PMID: 26338841 Free PMC article. Review.
-
Allocation concealment: a methodological review.J Eval Clin Pract. 2013 Aug;19(4):708-12. doi: 10.1111/jep.12032. Epub 2013 May 7. J Eval Clin Pract. 2013. PMID: 23648092 Review.
Cited by
-
Efficacy of two educational interventions about inhalation techniques in patients with chronic obstructive pulmonary disease (COPD). TECEPOC: study protocol for a partially randomized controlled trial (preference trial).Trials. 2012 May 21;13:64. doi: 10.1186/1745-6215-13-64. Trials. 2012. PMID: 22613015 Free PMC article. Clinical Trial.
-
Evaluating medical effectiveness for the california health benefits review program.Health Serv Res. 2006 Jun;41(3 Pt 2):1007-26. doi: 10.1111/j.1475-6773.2006.00517.x. Health Serv Res. 2006. PMID: 16704669 Free PMC article.
-
Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective.Pharmacoeconomics. 2004;22(5):321-41. doi: 10.2165/00019053-200422050-00006. Pharmacoeconomics. 2004. PMID: 15061682 Review.
-
Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'.BMC Med Res Methodol. 2009 Jun 11;9:34. doi: 10.1186/1471-2288-9-34. BMC Med Res Methodol. 2009. PMID: 19519887 Free PMC article.
-
Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.BMJ. 2008 Sep 18;337:a1284. doi: 10.1136/bmj.a1284. BMJ. 2008. PMID: 18801868 Free PMC article. Review.
References
-
- Cochrane AL. Effectiveness and efficiency: random reflections on health services. London: Nuffield Provincial Hospitals Trust; 1972. pp. 20–25.
-
- Committee for Evaluating Medical Technologies in Clinical Use. Assessing medical technologies. Washington DC: National Academy Press; 1985. pp. 76–78.
-
- US Congress; Office of Technology Assessment. Identifying health technologies that work: searching for evidence, OTA-H-608. Washington DC: US Government Printing Office; 1994. pp. 41–51.
-
- Weiss CH. Methods for studying programs and policies. 2nd ed. Upper Saddle River: Prentice Hall; 1998. Evaluation; pp. 229–233.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical